Reaction
Complications Of Transplanted Liver reporting signals
As of the last recalculation, Complications Of Transplanted Liver appears in 360 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 115.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 22 | 115.1 | 115.3 |
| Tacrolimus | 150 | 94.2 | 94.3 |
| Ganciclovir Sodium | 13 | 73.6 | 73.7 |
| Ganciclovir | 12 | 70.1 | 70.2 |
| Sevoflurane | 7 | 49.6 | 49.7 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 43.7 | 43.7 |
| Ursosiol | 14 | 43.3 | 43.3 |
| Tacrolimus Ointment 0.1% | 74 | 43.0 | 43.0 |
| Tacrolimus Extended-Release Capsules | 74 | 42.9 | 42.9 |
| Valganciclovir | 13 | 41.3 | 41.4 |
| Valganciclovir Hydrochloride | 13 | 41.3 | 41.4 |
| Sirolimus | 9 | 39.6 | 39.6 |
| Ursodiol | 14 | 38.6 | 38.7 |
| Rocuronium Bromide | 7 | 35.0 | 35.0 |
| Rifaximin | 12 | 34.2 | 34.2 |
| Sofosbuvir | 6 | 17.9 | 17.9 |